Detalhe da pesquisa
1.
Tertiary lymphoid structures improve immunotherapy and survival in melanoma.
Nature
; 577(7791): 561-565, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31942071
2.
Author Correction: Tertiary lymphoid structures improve immunotherapy and survival in melanoma.
Nature
; 580(7801): E1, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32238929
3.
Pervasive chromosomal instability and karyotype order in tumour evolution.
Nature
; 587(7832): 126-132, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32879494
4.
Transcriptomic signatures of tumors undergoing T cell attack.
Cancer Immunol Immunother
; 71(3): 553-563, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34272988
5.
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer.
Breast Cancer Res
; 23(1): 26, 2021 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33602273
6.
Molecular and genetic diversity in the metastatic process of melanoma.
J Pathol
; 233(1): 39-50, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24399611
7.
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.
JAMA
; 313(13): 1347-61, 2015 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-25849179
8.
BioMEL: a translational research biobank of melanocytic lesions and melanoma.
BMJ Open
; 14(2): e069694, 2024 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38309755
9.
Molecular patterns of resistance to immune checkpoint blockade in melanoma.
Nat Commun
; 15(1): 3075, 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38594286
10.
Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.
Hum Mol Genet
; 20(16): 3304-21, 2011 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21593217
11.
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers.
Breast Cancer Res
; 14(1): R33, 2012 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22348646
12.
DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotype.
JCI Insight
; 7(19)2022 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36040798
13.
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.
Hum Mol Genet
; 18(22): 4442-56, 2009 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19656774
14.
Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma.
J Immunother Cancer
; 9(7)2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34210820
15.
Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNγ, Following Recognition of Autologous Tumor-Antigens.
Front Immunol
; 12: 705422, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34707600
16.
Tumor genetic heterogeneity analysis of chronic sun-damaged melanoma.
Pigment Cell Melanoma Res
; 33(3): 480-489, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31811783
17.
CTLA-4 blockade boosts the expansion of tumor-reactive CD8+ tumor-infiltrating lymphocytes in ovarian cancer.
Sci Rep
; 10(1): 3914, 2020 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32127601
18.
Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma.
Nat Commun
; 11(1): 1714, 2020 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32238805
19.
Qualitative Analysis of Tumor-Infiltrating Lymphocytes across Human Tumor Types Reveals a Higher Proportion of Bystander CD8+ T Cells in Non-Melanoma Cancers Compared to Melanoma.
Cancers (Basel)
; 12(11)2020 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33198174
20.
The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in Melanoma.
Cell Rep
; 27(12): 3573-3586.e7, 2019 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31216476